Immunologically Active Cardiac Fibroblasts Expressing Major Histocompatibility Complex-II Promote Doxorubicin Cardiotoxicity
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart
Fu, X., Khalil, H., Kanisicak, O., Boyer, J. G., Vagnozzi, R. J., Maliken, B. D., Sargent, M. A., Prasad, V., Valiente-Alandi, I., Blaxall, B. C., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci98215 · Cited by 636
Luczak, E. D., & Leinwand, L. A. (2009) · Annual Review of Physiology · doi:10.1146/annurev.physiol.010908.163156 · Cited by 143
PDGFRα plays a crucial role in connective tissue remodeling
Horikawa, S., Ishii, Y., Hamashima, T., Yamamoto, S., Mori, H., Fujimori, T., Shen, J., Inoue, R., Nishizono, H., Itoh, H., et al. (2015) · Scientific Reports · doi:10.1038/srep17948 · Cited by 98
Research works printed but not linked: 44
- Gewirtz, 1999, A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics Adriamycin and daunorubicin, Biochem Pharmacol, 57, 727, 10.1016/S0006-2952(98)00307-4 · DOI · Paper page
- Wang, 2004, Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms: intermediacy of H(2)O(2)- and p53-dependent pathways, J Biol Chem, 279, 25535, 10.1074/jbc.M400944200 · DOI · Paper page
- Linders, 2024, A review of the pathophysiological mechanisms of doxorubicin-induced cardiotoxicity and aging, NPJ Aging, 10, 9, 10.1038/s41514-024-00135-7 · DOI · Paper page
- Suzuki, 1979, Cardiotoxicity of anthracycline antineoplastic drugs--clinicopathological and experimental studies, Jpn Circ J, 43, 1000, 10.1253/jcj.43.1000 · doi:10.1253/jcj.43.1000
- Zamorano, 2017, 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC), Eur J Heart Fail, 19, 9, 10.1002/ejhf.654 · DOI · Paper page
- Willis, 2019, Doxorubicin exposure causes subacute cardiac atrophy dependent on the striated muscle-specific ubiquitin ligase MuRF1, Circ Heart Fail, 12, 10.1161/CIRCHEARTFAILURE.118.005234 · DOI
- Jordan, 2018, Left ventricular mass change after anthracycline chemotherapy, Circ Heart Fail, 11, 10.1161/CIRCHEARTFAILURE.117.004560 · DOI
- Neilan, 2012, Left ventricular mass in patients with a cardiomyopathy after treatment with anthracyclines, Am J Cardiol, 110, 1679, 10.1016/j.amjcard.2012.07.040 · DOI · Paper page
- Young, 1981, The anthracycline antineoplastic drugs, N Engl J Med, 305, 139, 10.1056/NEJM198107163050305 · DOI · Paper page
- Bayer, 2024, Cytotoxic T cells drive doxorubicin-induced cardiac fibrosis and systolic dysfunction, Nat Cardiovasc Res, 3, 970, 10.1038/s44161-024-00507-y · DOI
- Borowiec, 2025, Interleukin-6 in anthracycline-related cardiac dysfunction: a comparison with myeloperoxidase and TNF-alpha, Int J Mol Sci, 26, 4071, 10.3390/ijms26094071 · doi:10.3390/ijms26094071
- Farbehi, 2019, Single-cell expression profiling reveals dynamic flux of cardiac stromal, vascular and immune cells in health and injury, Elife, 8, 10.7554/eLife.43882 · DOI · Paper page
- Kanisicak, 2016, Genetic lineage tracing defines myofibroblast origin and function in the injured heart, Nat Commun, 7, 10.1038/ncomms12260 · DOI · Paper page
- Zeigler, 2016, Computational modeling of cardiac fibroblasts and fibrosis, J Mol Cell Cardiol, 93, 73, 10.1016/j.yjmcc.2015.11.020 · DOI · Paper page
- Molkentin, 2017, Fibroblast-specific genetic manipulation of p38 mitogen-activated protein kinase in vivo reveals its central regulatory role in fibrosis, Circulation, 136, 549, 10.1161/CIRCULATIONAHA.116.026238 · DOI · Paper page
- Litvinukova, 2020, Cells of the adult human heart, Nature, 588, 466, 10.1038/s41586-020-2797-4 · DOI · Paper page
- Ren, 2020, Single-cell reconstruction of progression trajectory reveals intervention principles in pathological cardiac hypertrophy, Circulation, 141, 1704, 10.1161/CIRCULATIONAHA.119.043053 · DOI · Paper page
- Wang, 2020, Single-cell reconstruction of the adult human heart during heart failure and recovery reveals the cellular landscape underlying cardiac function, Nat Cell Biol, 22, 108, 10.1038/s41556-019-0446-7 · DOI · Paper page
- Sumida, 2024, The regulation and differentiation of regulatory T cells and their dysfunction in autoimmune diseases, Nat Rev Immunol, 24, 503, 10.1038/s41577-024-00994-x · DOI · Paper page
- Ngwenyama, 2022, Antigen presentation by cardiac fibroblasts promotes cardiac dysfunction, Nat Cardiovasc Res, 1, 761, 10.1038/s44161-022-00116-7 · DOI · Paper page
- Nevers, 2015, Left ventricular T-cell recruitment contributes to the pathogenesis of heart failure, Circ Heart Fail, 8, 776, 10.1161/CIRCHEARTFAILURE.115.002225 · DOI · Paper page
- Nevers, 2017, Th1 effector T cells selectively orchestrate cardiac fibrosis in nonischemic heart failure, J Exp Med, 214, 3311, 10.1084/jem.20161791 · DOI · Paper page
- Bayer, 2026, STING promotes CD8 T-cell cardiotropism and fibrosis from distinct cellular compartments in doxorubicin cardiomyopathy, Cardiovasc Res, 122, 1224, 10.1093/cvr/cvag098 · DOI · Paper page
- Guo, 2025, Human single-nucleus RNA sequencing identifies CD47 as a therapeutic target for doxorubicin-induced cardiomyopathy, Circulation, 152, 661, 10.1161/CIRCULATIONAHA.124.071217 · DOI
- Johansen, 2025, Transcription factor 21 regulates cardiac myofibroblast formation and fibrosis, Circ Res, 136, 44, 10.1161/CIRCRESAHA.124.325527 · DOI
- Trempus, 2023, Functional Pdgfra fibroblast heterogeneity in normal and fibrotic mouse lung, JCI Insight, 8, 10.1172/jci.insight.164380 · DOI
- Vivier, 2011, Innate or adaptive immunity? the example of natural killer cells, Science, 331, 44, 10.1126/science.1198687 · DOI · Paper page
- Zimmer, 2005, Clinical and immunological aspects of HLA class I deficiency, QJM, 98, 719, 10.1093/qjmed/hci112 · DOI · Paper page
- Ma, 2020, Temporary blockade of interferon-gamma ameliorates doxorubicin-induced cardiotoxicity without influencing the anti-tumor effect, Biomed Pharmacother, 130, 10.1016/j.biopha.2020.110587 · DOI
- Abe, 2022, Doxorubicin causes ferroptosis and cardiotoxicity by intercalating into mitochondrial DNA and disrupting Alas1-dependent heme synthesis, Sci Signal, 15, 10.1126/scisignal.abn8017 · DOI
- Christidi, 2021, Regulated cell death pathways in doxorubicin-induced cardiotoxicity, Cell Death Dis, 12, 339, 10.1038/s41419-021-03614-x · DOI · Paper page
- Buttmann, 2007, Interferon-beta is a potent inducer of interferon regulatory factor-1/2-dependent IP-10/CXCL10 expression in primary human endothelial cells, J Vasc Res, 44, 51, 10.1159/000097977 · DOI
- Rudick, 1996, Interferon beta induces interleukin-10 expression: relevance to multiple sclerosis, Ann Neurol, 40, 618, 10.1002/ana.410400412 · DOI · Paper page
- Lei, 2023, Cooperative sensing of mitochondrial DNA by ZBP1 and cGAS promotes cardiotoxicity, Cell, 186, 3013, 10.1016/j.cell.2023.05.039 · DOI · Paper page
- Osataphan, 2020, Effects of doxorubicin-induced cardiotoxicity on cardiac mitochondrial dynamics and mitochondrial function: insights for future interventions, J Cell Mol Med, 24, 6534, 10.1111/jcmm.15305 · DOI
- Zhou, 2001, Doxorubicin-induced persistent oxidative stress to cardiac myocytes, Toxicol Lett, 121, 151, 10.1016/S0378-4274(01)00329-0 · DOI · Paper page
- Diaz, 2024, Sex differences in the development of anthracycline-associated heart failure, J Card Fail, 30, 907, 10.1016/j.cardfail.2023.10.477 · DOI
- Su, 2024, Sex differences in doxorubicin-induced cardiotoxicity: insights from transcriptome analysis, Adv Therap, 7, 10.1002/adtp.202400036 · DOI
- Blum, 2021, Sex and tamoxifen confound murine experimental studies in cardiovascular tissue engineering, Sci Rep, 11, 8037, 10.1038/s41598-021-87006-3 · DOI
- Perrino, 2021, Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart, Cardiovasc Res, 117, 367, 10.1093/cvr/cvaa155 · DOI
- Asnani, 2018, Highly potent visnagin derivatives inhibit Cyp1 and prevent doxorubicin cardiotoxicity, JCI Insight, 3, 10.1172/jci.insight.96753 · DOI
- Twelves, 1991, Comparative pharmacokinetics of doxorubicin given by three different schedules with equal dose intensity in patients with breast cancer, Cancer Chemother Pharmacol, 28, 302, 10.1007/BF00685539 · doi:10.1007/bf00685539
- Zhu, 2009, Acute doxorubicin cardiotoxicity is associated with p53-induced inhibition of the mammalian target of rapamycin pathway, Circulation, 119, 99, 10.1161/CIRCULATIONAHA.108.799700 · DOI · Paper page
- Wielgat, 2023, Tamoxifen modulates the immune landscape of the tumour microenvironment: the paired siglec-5/14 checkpoint in anti-tumour immunity in an in vitro model of breast cancer, Int J Mol Sci, 24, 5512, 10.3390/ijms24065512 · DOI
Metadata
- Authors
- Zambrano, M. A., Bayer, A. L., Ramos, R. B., Stortini, C., Kaur, K., Bedi, K., Margulies, K. B., & Alcaide, P.
- Venue
- The American Journal of Pathology
- Publisher
- Elsevier BV
- Published
- 2026-09
- ISSN
- 0002-9440
- Cited by
- 0
- References
- 3
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Funders
- National Heart Lung and Blood Institute Division of Intramural Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.